Aerie Pharmaceutical

Podcast

Senior woman measuring blood glucose levels using smart phone to follow results

Podcast

'The Top Line': Genentech diversity miss, diabetes brand recall

This week on "The Top Line," we discuss a trial diversity miss and what's next as well as how poorly patients remember diabetes drug names.

Teresa Carey Aug 26, 2022 6:00am

fda

With La Jolla's Giapreza nod, FDA hits 46 for the year

Dec 22, 2017 9:50am

green

Aerie plots hiring push to roll out $400M Rhopressa

Dec 19, 2017 11:20am

Eye

Valeant says FDA has noted improvement at Bausch + Lomb plant

Aug 17, 2017 9:39am